People with life-threatening illnesses may eventually see improved access to experimental drugs at an earlier stage of the federal approval process, thanks to a bill that passed the House today.
By a vote of 250-169, the House passed federal “Right to Try” legislation, pushed by the Arizona-based libertarian Goldwater Foundation. This bill allows patients with what the government classifies as a “life-threatening” illness or condition to get access to drugs that have completed the first stage of clinical trial but are not yet fully approved by the Food and Drug Administration.
Most states have such laws on the books, but the federal government itself has lagged behind them in giving citizens permission to try experimental medication sooner if they’re dying.
Read the rest at Reason.com.
This Thanksgiving, We’re Being Served ‘Fake China Threats’
As a long-time critic of Washington’s obsession with the so-called “China threat”—and having written an entire book debunking it, The Fake China Threat—I could not in good conscience allow this year’s Report to Congress of the U.S.–China Economic and Security Review...
